Dyskinesias  >>  sodium oxybate  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
sodium oxybate / Generic mfg.
NCT00598078 / 2007-002222-30: Multiple-dose,Double-blind,Placebo-controlled Study of Sodium Oxybate in Patients With Essential Tremor

Completed
2
19
US
Sodium Oxybate, Placebo
Jazz Pharmaceuticals
Essential Tremor
08/08
12/08
NCT01961297: Voice Tremor in Spasmodic Dysphonia: Central Mechanisms and Treatment Response

Completed
2
53
US
Sodium oxybate, Xyrem
Kristina Simonyan, National Institutes of Health (NIH), National Institute on Deafness and Other Communication Disorders (NIDCD)
Spasmodic Dysphonia, Voice Tremor
06/17
06/17

Download Options